Needlestick injuries · preventing percutaneous exposure injuries caused by needles in healthcare personnel
It is very uncertain whether (RCT) Safe injection systems changes questionnaire reported Needlestick injuries 6 mo compared with regular systems RCT (very low certainty).
4 findings from 1 review
RR 0.42 [0.14, 1.25]
1 study · 154 participants
Very low
OR 0.2 [0.04, 0.96]
1 study · 144 participants
Very low
OR 1.2 [0.51, 2.84]
1 study · 533 participants
Very low
Show 1 more finding
Needlestick injury rate · preventing percutaneous exposure injuries caused by needles in healthcare personnel
It is very uncertain whether (CBA) Safe injection systems changes needlestick injury rate compared with regular systems (very low certainty).
1 finding from 1 review
Number of participants with symptomatic UTI · primary VUR
Endoscopic injection treatment showed no clear difference in all symptomatic UTI by 1 to 2 years: endoscopic correction +… compared with antibiotics alone (low certainty).
1 finding from 1 review
Febrile UTI by 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone · primary VUR
Endoscopic injection treatment showed no clear difference in febrile UTI by 1 to 2 years: endoscopic correction + antibiotics… compared with antibiotics alone (low certainty).
1 finding from 1 review
Repeat positive urine culture · primary VUR
It is very uncertain whether endoscopic injection treatment changes repeat positive urine culture by 1 year compared with antibiotics alone (very low certainty).
1 finding from 1 review
Total new and progressive Renal parenchymal abnormalities on DMSA scan at 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone (unit of analysis: children) · primary VUR
Endoscopic injection treatment showed no clear difference in total new and progressive Renal parenchymal abnormalities on DMSA… compared with antibiotics alone (low certainty).
1 finding from 1 review
Resolution of VUR · primary VUR
Endoscopic injection treatment may leads to higher resolution of VUR (grade 0) for endoscopic correction + antibiotics… compared with antibiotics alone (low certainty).
1 finding from 1 review
Microbial resistance to prophylactic drug · primary VUR
It is very uncertain whether endoscopic injection treatment changes microbial resistance to the prophylactic drug compared with antibiotics alone (very low certainty).
1 finding from 1 review
Health‐related quality of life · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether percutaneous alcohol injection changes mortality at maximal compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Cancer‐related mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
Percutaneous alcohol injection may leads to higher cancer‐related mortality at maximal compared with radiofrequency ablation (low certainty).
1 finding from 1 review
Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether percutaneous alcohol injection changes serious adverse events (number of participants) compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Serious adverse events (number of events) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether percutaneous alcohol injection changes serious adverse events (number of events) compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Local progression · 1088 patients with early HCC
1 finding from 1 review
Rate of complications · 1088 patients with early HCC
1 finding from 1 review
Length of hospital stay · 1088 patients with early HCC
1 finding from 1 review
Overall survival · 1088 patients with early HCC
1 finding from 1 review
2‐year survival · 1088 patients with early HCC
1 finding from 1 review
Event‐free survival · 1088 patients with early HCC
1 finding from 1 review
Treatment‐related adverse effects · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found